Navigation Links
New defibrillator signals doctor of patient's irregular heartbeat or device malfunction

Loyola first in U.S. to implant new FDA-approved device

In a major advance for heart patients, Loyola University Health System is the first hospital in the U.S. to implant into a patient a new FDA-approved defibrillator which automatically signals the doctor via wireless satellite transmission if the patient's heart beats abnormally or if the device malfunctions, e.g., battery failure.

When a patient's status changes, a built-in microchip of Biotronik's Lumos DR-T implantable cardioverter defibrillator (ICD) sends a signal to a satellite via a small transmitter that can be placed on a nightstand, worn on a belt or kept in a purse. In addition, Biotronik's Home Monitoring system virtually instantaneously sends a beat-by-beat record (similar to an electrocardiogram (ECG)) of any heart rhythm abnormality which the doctor can view on a secure website.

"The patient doesn't have to press any button or call the doctor to activate the system," said cardiac electrophysiologist Dr. Niraj Varma, associate professor of medicine, division of cardiology, Loyola University Chicago Stritch School of Medicine, and director of the cardiac electrophysiology lab, Loyola University Health System, Maywood, Ill. The notification signal is automatically generated, even if the patient is unaware of any problems. The doctor can program the device to send an alert for specific reasons, such as a significant increase in the number of irregular heartbeat (arrhythmia) episodes, as well as the preferred alert method, i.e., via email, cell phone, fax or page.

"With this surveillance system, physicians for the first time have a way to monitor non-hospitalized heart patients 24-hours-a-day, seven days a week," he said. "It will enable us to identify problems early on as well as help prevent problems."

Implanted in the chest, the ICD is a small electronic device which shocks the heart back into a healthy rhythm if it detects an abnormal heartbeat. Irregular heartbeat (arrhythmia) is a major cause of death following heart attacks. Studies have shown mortality is lower in ICD-treated patients.

"The new ICD provides faster delivery of care to patients and also reduces the number of times a patient has to go to the doctor's office for follow-up visits," said Varma, who specializes in treatment of arrhythmias.

Because patients' heart muscle pumping action can be poor as a result of the heart attack, it is important to monitor heart activity. Now it can be done 24-hours-a-day, seven-days-a-week. Varma implanted the device into a Loyola patient on Friday, August 26, 2005.

Loyola University Health System's heart program is ranked as the top program in Illinois, according to U.S. News & World Report's annual survey of more than 6,000 hospitals nationwide. This is the third year in a row that Loyola has achieved the top spot for Heart Care and Heart Surgery in the state.

Loyola opened its new 10,000-square-foot Center for Heart and Vascular Medicine on the Loyola University Medical Center campus. Loyola's 3,500-square-foot Sally & Jim Dowdle Electrophysiology Laboratories includes two dedicated fluoroscopy suites equipped with state-of-the-art multichannel digital recording systems, 3-D mapping systems, intracardiac echocardiography and a laser system.


Source:Loyola University Health System

Related biology news :

1. Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure
2. Plants respond similarly to signals from friends, enemies
3. Edible bivalves as a source of human pathogens: signals between vibrios and the bivalve host.
4. Scientists discover that three overlapping signals in embryo help get the backbone right
5. After a time-shift, mixed signals from the circadian clock
6. Researchers make surprise discovery that some neurons can transmit three signals at once
7. Structure-building cell signals also may influence learning and memory
8. Fox Chase study shows that weakened T-cell receptor signals change T-cell lineage
9. Overbearing colored light may reveal a second mechanism by which birds interpret magnetic signals
10. Mayo Clinic collaboration discovers protein amplifies DNA injury signals
11. Research details how a virus hijacks cell signals to cause infection
Post Your Comments:

(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology: